Data gathered: May 17
Alternative Data for Eli Lilly and Company
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 918 | Sign up | Sign up | Sign up | |
Sentiment | 70 | Sign up | Sign up | Sign up | |
Webpage traffic | 3,507,000 | Sign up | Sign up | Sign up | |
Employee Rating | 82 | Sign up | Sign up | Sign up | |
Google Trends | 33 | Sign up | Sign up | Sign up | |
Patents | 451 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 838 | Sign up | Sign up | Sign up | |
Facebook Followers | 243,432 | Sign up | Sign up | Sign up | |
Instagram Followers | 34,408 | Sign up | Sign up | Sign up | |
Reddit Mentions | 7 | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 44 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 17,990 | Sign up | Sign up | Sign up | |
Twitter Followers | 143,098 | Sign up | Sign up | Sign up | |
Twitter Mentions | 303 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | 46 | Sign up | Sign up | Sign up | |
ESG | 66 | Sign up | Sign up | Sign up | |
Business Outlook | 85 | Sign up | Sign up | Sign up | |
Linkedin Employees | 42,794 | Sign up | Sign up | Sign up |
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
Price | $771.12 |
Target Price | Sign up |
Volume | 2,250,000 |
Market Cap | $748B |
Year Range | $523.32 - $792.28 |
Dividend Yield | 0.66% |
PE Ratio | 116.25 |
Revenue per Employee | $921,336 |
Industry | Drug Manufacturers |
In the news
Eli Lilly and Company (NYSE:LLY) Shares Up 2% on Analyst UpgradeMay 16 - ETF Daily News |
|
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Arvinas Holding Company (ARVN) and Progyny (PGNY)May 15 - TipRanks |
|
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Celcuity (CELC) and 89bio (ETNB)May 15 - TipRanks |
|
JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm TherapeuticsMay 15 - GlobeNewswire |
|
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound CopiesMay 14 - Yahoo |
|
New Analyst Adjustments Prove Little Help to Eli Lilly (NYSE:LLY)May 13 - TipRanks |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q1 '24 | 8.77B | 3.51B | 5.26B | 2.24B | 3.21B | 2.580 |
Q4 '23 | 9.35B | 4.17B | 5.18B | 2.19B | 3.6B | 2.490 |
Q3 '23 | 9.5B | 3.55B | 5.95B | -57M | 6.4B | 0.100 |
Q2 '23 | 8.31B | 3.62B | 4.69B | 1.76B | 2.32B | 2.110 |
Q1 '23 | 6.96B | 3.26B | 3.7B | 1.34B | 1.7B | 1.620 |
Insider Transactions View All
Zakrowski Donald A filed to sell 7,880 shares at $753.6. March 11 '24 |
LILLY ENDOWMENT INC filed to sell 98,898,810 shares at $793.1. February 20 '24 |
LILLY ENDOWMENT INC filed to sell 99,015,376 shares at $778.8. February 20 '24 |
LILLY ENDOWMENT INC filed to sell 99,067,394 shares at $764.3. February 20 '24 |
LILLY ENDOWMENT INC filed to sell 99,014,198 shares at $780.1. February 20 '24 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
Johnson & JohnsonJNJ |
$154.28 0% | 60 |
|
PfizerPFE |
$28.92 0% | 39 |
|
AstrazenecaAZN |
$77.04 0% | 58 |
|
AbbVieABBV |
$164.33 0% | 58 |
|
TherapeuticsMDTXMD |
$2.12 0% | 39 |
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Thomas Tuberville Republican |
May 15, 24 | Sell | $15K - $50K |
Rohit Khanna Democrat |
May 6, 24 | Sell | $15K - $50K |
Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
Read more about Eli Lilly and Company (LLY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eli Lilly and Company?
The Market Cap of Eli Lilly and Company is $748B.
What is Eli Lilly and Company's PE Ratio?
As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 116.25.
How Many People Work at Eli Lilly and Company?
As of our latest update, Eli Lilly and Company employed approximately 39,000 people worldwide. However, it's important to note that Eli Lilly and Company's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Eli Lilly and Company's revenue per employee?
$921,336. To calculate Eli Lilly and Company's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Eli Lilly and Company?
Currently, the price of one share of Eli Lilly and Company stock is $771.12.
How can I analyze the LLY stock price chart for investment decisions?
The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.
Does LLY offer dividends to its shareholders?
Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.66%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Eli Lilly and Company?
Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.